Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Nadine Houede
Based on 25 articles published since 2009
(Why 25 articles?)
||||
Expertise Level
The expertise of Nadine Houede ranks in the
  • Top 0.59%
  • ... of 132,850 published authors worldwide on Prostatic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 25 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Houedé, Nadine   ·   Houede, N   ·   Houede, Nadine   ·   Houédé, Nadine   ·   Houédé, N
Work Locations
Details
Most likely:    Miscellaneous cities in France      
2017
  • Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands. · US Oncology Research, Houston, Texas3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Yale Cancer Center, Division of Oncology, Department of Medicine, New Haven, Connecticut. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin. · University Hospital del Mar-IMIM, Barcelona, Spain10Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · US Oncology Research, Houston, Texas11Rocky Mountain Cancer Centers, Aurora, Colorado. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, England. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare " Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, England. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, New Jersey. · Pubmed 27560549
  • Department of Pathology, CHU de tours, Université François Rabelais, Tours, France. · INSERM UMR 1069, Tours, France. · Department of Urology, CHU de Tours, Pres Centre Val de Loire, Université François Rabelais de Tours, Tours, France. · Service d'Urologie, CHU de Poitiers, Université de Poitiers, Poitiers, France. · Department of Urology, Henri Mondor Hospital, AP-HP, Créteil, France. · Department of Pathology and Tissue Biobank Unit, Henri Mondor Hospital, AP-HP, Créteil, France. · Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. · Department of Pathology, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. · Department of Urology, Pitié- Salpétrière Hospital, Assistance Publique Hôpitaux de Paris, University Pierre et Marie Curie, Paris 6, Paris, France. · Department of Pathology, Pitié-Salpétrière Hospital, Assistance Publique Hôpitaux de Paris, University Pierre et Marie Curie, Paris 6, Paris, France. · Department of Medical Oncology, Groupe Hospitalier Universitaire Caremeau, Nîmes, France. · Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Toulouse, France. · Laboratoire de Biochimie et Biologie moléculaire, CHRU de Tours, INSERM U930, Université François-Rabelais, Tours, France. · Pubmed 28699202
2015
  • Oncologie médicale, CHU Caremeau, place du Pr-Robert-Debré, 30029 Nîmes cedex 9, France. Electronic address: · Service d'urologie, hôpital de Milétrie, avenue Jacques-Cœur, 86000 Poitiers, France. · Pubmed 25684391
  • Institut Gustave Roussy, Villejuif, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Centre François Baclesse, Caen, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Institut Paoli Calmettes, Marseille, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Centre Hospitalier Départemental, La Roche-sur-Yon, France. · Centre Antoine Lacassagne, Nice, France. · Centre Hospitalier de Nimes, Nimes, France. · Institut Claudius Regaud, Toulouse, France. · Hôpital Foch, Paris, France. · Centre Alexis Vautrin, Nancy, France. · Clinique Sainte-Marguerite, Hyères, France. · Centre Hospitalier La Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Centre Léon Bérard, Lyon, France. · Hôpital Saint-André, Bordeaux, France. · Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France. · Hôpital Européen Georges Pompidou, Paris, France. · CHU Dupuytren, Limoges, France. · Centre Henri Becquerel, Rouen, France. · Centre Médical Oncogard, Nimes, France. · Hôpital Henri-Mondor, Créteil, France. · Hôpital Bretonneau, Tours, France. · Hôpital Saint-Joseph, Paris, France. · Institut Curie, Paris, France. · Clinique Sainte-Catherine, Avignon, France. · Unicancer, Paris, France. · Hôpital Saint-Louis, Paris, France. · Pubmed 26028518
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
2014
  • Department of Medical Oncology, Nimes University Hospital, Nimes, France; · Clinical Research and Clinical Epidemiology Unit, Bergonié Cancer Institute, Bordeaux, France; · Department of Oncology, Claudius Régaud Cancer Center, Toulouse, France; · Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France; · Department of Medical Oncology, CHD La Roche sur Yon, La Roche sur Yon, France; · Alienor Farma, Parc Scientifique Unitec 1, Pessac, France; · Centre Hospitalier de Pellegrin, Laboratoire de Pharmacologie et Toxicologie, Bordeaux, France; · INSERM U862, Neurocentre Magendie, Bordeaux, France. · Pubmed 25355844
2017
  • Radiobiology Unit, INSERM U1194, Institut du Cancer de Montpellier (ICM). · Department of Nuclear Medicine, Institut du Cancer de Montpellier (ICM), Montpellier. · Urology Department, Andrology and Renal Transplantation, CHU Rangueil, Toulouse. · Medical Oncology Department, Hôpital Européen Georges Pompidou. · Oncology Department, Institut Curie. · Department of Nuclear Medicine, CHU, Clermont-Ferrand. · Radiotherapy Department, Hôpital Saint Louis, Paris. · Department of Nuclear Medicine, CHRU, Lille. · Urology Department, Institut Mutualiste Montsouris. · Intergroupe coopérateur francophone de recherche en onco-urologie, Paris. · Urology Department, Clinique BeauSoleil, Montpellier. · Medical Oncology Department, Institut de Cancérologie du Gard - CHU Caremeau, Nîmes, France. · Pubmed 28919714
2015
  • Department of Medical Oncology, Nîmes University Hospital, Nîmes, France. · INSERM U1194, Montpellier, France. · Department of Medical Oncology, Curie Institute, Paris, France. · Biostatistics Unit, ICM - Montpellier Cancer Institute, Montpellier, France. · Department of Medical Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. · Department of Medical Oncology, François Baclesse Cancer Centre, Caen, France. · Department of Medical Oncology, Paoli Calmette Institute, Marseille, France. · Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. · Department of Medical Oncology, Leon Bérard Cancer Centre, Lyon, France. · Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medical Oncology, Lyon University Hospital, Lyon, France. · Department of Medical Oncology, Eugène Marquis Cancer Centre, Rennes, France. · Department of Medical Oncology, Montpellier University Hospital, Montpellier, France. · Department of Medical Oncology, Bergonié Cancer Institute, Bordeaux, France. · INSERM U1194, Montpellier, France. · Department of Urology, Clinique Beausoleil, Montpellier, France. · INSERM U1194, Montpellier, France. · Department of Radiation Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. · Pubmed 25884302
Probable:    Miscellaneous institutions in Bordeaux      
2016
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
2014
2010
  • Service de Radiothérapie, Centre Régional de Lutte Contre le Cancer, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux cedex, France. · Pubmed 20810300
Probable:    CHU Bordeaux      
2014
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 25 total) written by Nadine Houede about Prostatic Neoplasms:

  • LINE-1 as a therapeutic target for castration-resistant prostate cancer. 2018
  • Radium 223 dichloride for prostate cancer treatment. 2017
  • Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study. 2017
  • Ductal adenocarcinoma of the prostate: Clinical and biological profiles. 2017
  • Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1. 2016
  • Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial. 2016
  • [Tasquinimod: How to act on microenvironment in metastatic prostate cancer]. 2015
  • Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. 2015
  • Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial. 2015
  • Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study. 2015
Show List of Full Article Records
Google Searches

Learn more about Nadine Houede using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in France
Miscellaneous institutions in Bordeaux
CHU Bordeaux
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in France
2017
  • Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands. · US Oncology Research, Houston, Texas3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Yale Cancer Center, Division of Oncology, Department of Medicine, New Haven, Connecticut. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin. · University Hospital del Mar-IMIM, Barcelona, Spain10Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · US Oncology Research, Houston, Texas11Rocky Mountain Cancer Centers, Aurora, Colorado. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, England. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare " Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, England. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, New Jersey. · Pubmed 27560549
  • Department of Pathology, CHU de tours, Université François Rabelais, Tours, France. · INSERM UMR 1069, Tours, France. · Department of Urology, CHU de Tours, Pres Centre Val de Loire, Université François Rabelais de Tours, Tours, France. · Service d'Urologie, CHU de Poitiers, Université de Poitiers, Poitiers, France. · Department of Urology, Henri Mondor Hospital, AP-HP, Créteil, France. · Department of Pathology and Tissue Biobank Unit, Henri Mondor Hospital, AP-HP, Créteil, France. · Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. · Department of Pathology, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. · Department of Urology, Pitié- Salpétrière Hospital, Assistance Publique Hôpitaux de Paris, University Pierre et Marie Curie, Paris 6, Paris, France. · Department of Pathology, Pitié-Salpétrière Hospital, Assistance Publique Hôpitaux de Paris, University Pierre et Marie Curie, Paris 6, Paris, France. · Department of Medical Oncology, Groupe Hospitalier Universitaire Caremeau, Nîmes, France. · Department of Urology, Andrology and Renal Transplantation, CHU Rangueil, Toulouse, France. · Laboratoire de Biochimie et Biologie moléculaire, CHRU de Tours, INSERM U930, Université François-Rabelais, Tours, France. · Pubmed 28699202
2015
  • Oncologie médicale, CHU Caremeau, place du Pr-Robert-Debré, 30029 Nîmes cedex 9, France. Electronic address: · Service d'urologie, hôpital de Milétrie, avenue Jacques-Cœur, 86000 Poitiers, France. · Pubmed 25684391
  • Institut Gustave Roussy, Villejuif, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Centre François Baclesse, Caen, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Institut Paoli Calmettes, Marseille, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Centre Hospitalier Départemental, La Roche-sur-Yon, France. · Centre Antoine Lacassagne, Nice, France. · Centre Hospitalier de Nimes, Nimes, France. · Institut Claudius Regaud, Toulouse, France. · Hôpital Foch, Paris, France. · Centre Alexis Vautrin, Nancy, France. · Clinique Sainte-Marguerite, Hyères, France. · Centre Hospitalier La Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Centre Léon Bérard, Lyon, France. · Hôpital Saint-André, Bordeaux, France. · Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France. · Hôpital Européen Georges Pompidou, Paris, France. · CHU Dupuytren, Limoges, France. · Centre Henri Becquerel, Rouen, France. · Centre Médical Oncogard, Nimes, France. · Hôpital Henri-Mondor, Créteil, France. · Hôpital Bretonneau, Tours, France. · Hôpital Saint-Joseph, Paris, France. · Institut Curie, Paris, France. · Clinique Sainte-Catherine, Avignon, France. · Unicancer, Paris, France. · Hôpital Saint-Louis, Paris, France. · Pubmed 26028518
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
2014
  • Department of Medical Oncology, Nimes University Hospital, Nimes, France; · Clinical Research and Clinical Epidemiology Unit, Bergonié Cancer Institute, Bordeaux, France; · Department of Oncology, Claudius Régaud Cancer Center, Toulouse, France; · Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France; · Department of Medical Oncology, CHD La Roche sur Yon, La Roche sur Yon, France; · Alienor Farma, Parc Scientifique Unitec 1, Pessac, France; · Centre Hospitalier de Pellegrin, Laboratoire de Pharmacologie et Toxicologie, Bordeaux, France; · INSERM U862, Neurocentre Magendie, Bordeaux, France. · Pubmed 25355844
2017
  • Radiobiology Unit, INSERM U1194, Institut du Cancer de Montpellier (ICM). · Department of Nuclear Medicine, Institut du Cancer de Montpellier (ICM), Montpellier. · Urology Department, Andrology and Renal Transplantation, CHU Rangueil, Toulouse. · Medical Oncology Department, Hôpital Européen Georges Pompidou. · Oncology Department, Institut Curie. · Department of Nuclear Medicine, CHU, Clermont-Ferrand. · Radiotherapy Department, Hôpital Saint Louis, Paris. · Department of Nuclear Medicine, CHRU, Lille. · Urology Department, Institut Mutualiste Montsouris. · Intergroupe coopérateur francophone de recherche en onco-urologie, Paris. · Urology Department, Clinique BeauSoleil, Montpellier. · Medical Oncology Department, Institut de Cancérologie du Gard - CHU Caremeau, Nîmes, France. · Pubmed 28919714
2015
  • Department of Medical Oncology, Nîmes University Hospital, Nîmes, France. · INSERM U1194, Montpellier, France. · Department of Medical Oncology, Curie Institute, Paris, France. · Biostatistics Unit, ICM - Montpellier Cancer Institute, Montpellier, France. · Department of Medical Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. · Department of Medical Oncology, François Baclesse Cancer Centre, Caen, France. · Department of Medical Oncology, Paoli Calmette Institute, Marseille, France. · Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. · Department of Medical Oncology, Leon Bérard Cancer Centre, Lyon, France. · Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medical Oncology, Lyon University Hospital, Lyon, France. · Department of Medical Oncology, Eugène Marquis Cancer Centre, Rennes, France. · Department of Medical Oncology, Montpellier University Hospital, Montpellier, France. · Department of Medical Oncology, Bergonié Cancer Institute, Bordeaux, France. · INSERM U1194, Montpellier, France. · Department of Urology, Clinique Beausoleil, Montpellier, France. · INSERM U1194, Montpellier, France. · Department of Radiation Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. · Pubmed 25884302
Miscellaneous institutions in Bordeaux
2016
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
2014
2010
  • Service de Radiothérapie, Centre Régional de Lutte Contre le Cancer, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux cedex, France. · Pubmed 20810300
Unspecified
2016
  • Matthew Smith, Massachusetts General Hospital, Boston, MA · Johann De Bono, Royal Marsden Hospital, Sutton · Syed Hussain, University of Liverpool, Liverpool, United Kingdom · Cora Sternberg, San Camillo and Forlanini Hospitals, Rome · Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola · Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy · Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce · Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris · Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon · Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes · Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France · Michael Krainer, Medical University of Vienna, Vienna, Austria · Andries Bergman, Netherlands Cancer Institute, Amsterdam · Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands · Wolfgang Hoelzer, Praxis für Urologie · Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin · Martin Bögemann, University of Muenster Medical Center, Muenster · Susan Feyerabend, Studienpraxis Urologie, Nürtingen · Arnulf Stenzl, University Hospital, Tübingen, Germany · Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada · Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO · Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego · David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA · and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
2014
  • M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA · Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris · Nadine Houede, Institut Bergonie, Bordeaux · Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France · Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan · Lisa Sengeløv, Herlev Hospital, Herlev · Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark · Fred Saad, University of Montreal, Montreal, Canada · Peter Ostler, Mount Vernon Hospital, Northwood, Middlesex · Robert Jones, Beatson West of Scotland Cancer Centre, Glasgow · Amit Bahl, Bristol Haematology and Oncology Centre, Bristol, UK · Arnulf Stenzl, Eberhard-Karls-University Medical School, Tübingen · Juergen Gschwend, Technical University of Munich, Munich, Germany · Fredrik Laestadius and Anders Ullèn, Karolinska University Hospital, Stockholm, Sweden · Daniel Castellano, I_12 Research Institute, University Hospital 12 de Octubre, Madrid, Spain · Edna Chow Maneval, Shaw-Ling Wang, and Isan Chen, Pfizer Oncology, La Jolla, CA · and Maria Jose Lechuga and Jolanda Paolini, Pfizer Oncology, Milan, Italy. · Pubmed 24323035
  • Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Institut Bergonié, Bordeaux Department of Medical Oncology, CHU Caremeau, Nîmes. · Urology Department, Saint Augustin Clinic, Bordeaux. · Department of Pathology CAP, Bordeaux. · Department of Radiotherapy, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux · Pubmed 24692580
CHU Bordeaux
2014
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
12 Other Locations Show
Yearly article counts 01327602220
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.